TABLE 1.
Milan System for Reporting Salivary Gland Cytopathology Categories, Appurtenant Risk of Malignancy, and Advised Management Strategy as Reported by Faquin et al4
| Diagnostic Category | Risk of Malignancy, % | Management |
|---|---|---|
| I. Nondiagnostic | 25 | Clinical and radiological correlation/repeat FNAC |
| II. Nonneoplastic | 10 | Clinical follow‐up and radiological correlation |
| III. AUS | 20 | Repeat FNAC or surgery |
| IVa. Neoplasm: benign | <5 | Surgery or clinical follow‐up |
| IVb. SUMP | 35 | Surgery |
| V. Suspected malignant | 60 | Surgery |
| VI. Malignant | 90 | Surgery |
Abbreviations: AUS, atypia of unknown significance; FNAC, fine‐needle aspiration cytology; SUMP, salivary gland neoplasm of unknown malignant potential.